Keywords:
Supply Chain Risk Management, Pandemic, Drug Distribution, Pharmaceutical Logistics, Risk Mitigation, Inventory Management, Public Health Supply Chain, Contingency Planning, Supply Disruptions, Demand Surge
Abstract
The global distribution of pharmaceutical products during pandemics presents unique and critical supply chain risks that can significantly impact public health outcomes. This manuscript explores the challenges and strategies involved in managing risks within the drug distribution supply chain under pandemic conditions. Emphasis is placed on the identification of risk factors such as demand surge, supply disruptions, regulatory hurdles, and logistic constraints. Through a comprehensive literature review and analysis, various risk mitigation frameworks, inventory management techniques, and coordination mechanisms are examined. The study also highlights the importance of strategic partnerships, robust communication channels, and contingency planning to enhance resilience. This research aims to provide a structured understanding of supply chain risk management (SCRM) tailored specifically for pandemic drug distribution, offering insights that are vital for policymakers, healthcare providers, and supply chain professionals.
References
- Christopher, M., & Peck, H. (2004). Building the resilient supply chain. International Journal of Logistics Management, 15(2), 1–13. https://doi.org/10.1108/09574090410700275
- Chopra, S., & Sodhi, M. S. (2004). Managing risk to avoid supply-chain breakdown. MIT Sloan Management Review, 46(1), 53–61.
- Knemeyer, A. M., Zinn, W., & Eroglu, C. (2009). Proactive planning for catastrophic events in supply chains. Journal of Operations Management, 27(2), 141-153. https://doi.org/10.1016/j.jom.2008.06.001
- Lee, H. L., Padmanabhan, V., & Whang, S. (1997). The bullwhip effect in supply chains. Sloan Management Review, 38(3), 93-102.
- Lee, H. L., & Billington, C. (1993). Material management in decentralized supply chains. Operations Research, 41(5), 835-847. https://doi.org/10.1287/opre.41.5.835
- Reid, R. H., & Schuurman, P. (2001). Pharmaceutical supply chain logistics: challenges and solutions. Journal of Business Logistics, 22(2), 95-106.
- Sheffi, Y. (2005). The resilient enterprise: overcoming vulnerability for competitive advantage. MIT Press.
- Tang, C. S. (2006). Robust strategies for mitigating supply chain disruptions. International Journal of Logistics: Research and Applications, 9(1), 33-45. https://doi.org/10.1080/13675560500405584
- Trkman, P., McCormack, K., De Oliveira, M. P. V., & Ladeira, M. B. (2010). The impact of business analytics on supply chain performance. Decision Support Systems, 49(3), 318-327. https://doi.org/10.1016/j.dss.2010.12.006
How to cite
Nitesh Dubey (2013). Supply Chain Risk Management in Pandemic Drug Distribution. International Journal for Research in Management & Pharmacy, 2(4), 10-16.
Licence
This article is open access, published under the CC BY 4.0 licence. Copyright remains with the authors.
If the issue persists, you can use the old publisher details where you get it published.